{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T05:25:37Z","timestamp":1775366737391,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dayanand Medical College and Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe alcoholic hepatitis (SAH) is associated with high mortality. Numerous studies and meta-analysis have reported that corticosteroids reduce the 28-day mortality in SAH, but not the 6-month mortality. Therefore, newer treatments for SAH need to be studied. A pilot study from our group had recently treated ten patients with SAH with bovine colostrum (BC) [20\u00a0g thrice in a day for 8\u00a0weeks] and prednisolone. This therapy improved the biological functions and 3-month mortality. However, as more and more data showed the failure of corticosteroids to improve the 3- and 6-month mortality, especially in patients with high mDF and MELD scores, we planned this trial to study the safety and efficacy of BC (without corticosteroids) in the treatment of SAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This is a multicenter, parallel, double-blind, randomized (1:1) placebo-controlled trial, which will enroll 174 patients with SAH from 5 academic centers in the India. Patients will receive freeze-dried BC or placebo by random 1:1 allocation for 4\u00a0weeks. The primary outcome measure is survival at 3\u00a0months. The secondary outcome measures are survival at 1\u00a0month, change in mDF and MELD scores, change in endotoxin and cytokines (alpha TNF, IL6, and IL8) levels, number of episodes of sepsis [pneumonia, spontaneous bacterial peritonitis (SBP), cellulitis, urinary tract infection (UTI)] from baseline to 4\u00a0weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study will evaluate the safety and efficacy of bovine colostrum in improving the survival of patients with SAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT02473341. Prospectively registered on June 16, 2015.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07505-8","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T05:02:04Z","timestamp":1691730124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A multicenter double-blind, placebo-controlled randomized trial to evaluate the safety and efficacy of bovine colostrum in the treatment of severe alcoholic hepatitis (SAH)"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9194-2110","authenticated-orcid":false,"given":"S. S.","family":"Sidhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dusseja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Nijhawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"4","key":"7505_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","volume":"150","author":"DW Crabb","year":"2016","unstructured":"Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016;150(4):785\u201390.","journal-title":"Gastroenterology"},{"key":"7505_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2005.06.003","volume":"43","author":"P Mathurin","year":"2005","unstructured":"Mathurin P. Corticosteroids for alcoholic hepatitis\u2014what\u2019s next? J Hepatol. 2005;43:526\u201333.","journal-title":"J Hepatol"},{"key":"7505_CR3","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758\u201369.","journal-title":"N Engl J Med"},{"issue":"4","key":"7505_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","volume":"150","author":"DW Crabb","year":"2016","unstructured":"Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016;150(4):785\u201390.","journal-title":"Gastroenterology."},{"key":"7505_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-14-262","volume":"14","author":"E Forrest","year":"2013","unstructured":"Forrest E, Mellor J, Stanton L, Bowers M, Ryder P, Austin A, Day C, Gleeson D, O\u2019Grady J, Masson S, McCune A. Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials. 2013;14:1\u20137.","journal-title":"Trials"},{"issue":"2","key":"7505_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","volume":"155","author":"A Louvet","year":"2018","unstructured":"Louvet A, Thursz MR, Kim DJ, et al. Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials. Gastroenterology. 2018;155(2):458\u201368.","journal-title":"Gastroenterology"},{"issue":"4","key":"7505_CR7","doi-asserted-by":"publisher","first-page":"e0195857","DOI":"10.1371\/journal.pone.0195857","volume":"13","author":"E Hughes","year":"2018","unstructured":"Hughes E, Hopkins LJ, Parker R. Correction: survival from alcoholic hepatitis has not improved over time at 28 days, 90 days, and 180 days. PLoS One. 2018;13(4):e0195857. https:\/\/doi.org\/10.1371\/journal.pone.0195857. Correction.","journal-title":"PLoS One"},{"issue":"4","key":"7505_CR8","doi-asserted-by":"publisher","first-page":"CD001511","DOI":"10.1002\/14651858.CD001511.pub4","volume":"4","author":"CS Pavlov","year":"2019","unstructured":"Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C. Glucocorticosteroids for people with alcoholic hepatitis. Cochrane Database Syst Rev. 2019;4(4):CD001511. https:\/\/doi.org\/10.1002\/14651858.CD001511.pub4. PMID: 30964545; PMCID: PMC6455893.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"7505_CR9","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","volume":"75","author":"JP Arab","year":"2021","unstructured":"Arab JP, D\u00edaz LA, Baeza N, Idalsoaga F, Fuentes-L\u00f3pez E, Arnold J, Ram\u00edrez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study. J Hepatol. 2021;75(5):1026\u201333.","journal-title":"J Hepatol"},{"key":"7505_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12664-018-0842-0","volume":"2","author":"R Daswani","year":"2018","unstructured":"Daswani R, Kumar A, Anikhindi SA, et al. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: experience with 183 patients at a tertiary care centre from India. Indian J Gastroenterol. 2018;2:141\u201352.","journal-title":"Indian J Gastroenterol"},{"issue":"9","key":"7505_CR11","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/ajg.2014.154","volume":"109","author":"V Singh","year":"2014","unstructured":"Singh V, Sharma AK, Narasimhan LR, Bhalla A, Sharma N, Sharma R. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am J Gastroenterol. 2014;109(9):1417\u201323.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"7505_CR12","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cgh.2018.01.040","volume":"16","author":"V Singh","year":"2018","unstructured":"Singh V, Keisham A, Bhalla A, et al. Efficacy of granulocyte colony-stimulating factor and N acetylcysteine therapies in patients with severe alcoholic hepatitis. Clin Gastroenterol Hepatol. 2018;16(10):1650\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"7505_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jceh.2021.07.010","volume":"12","author":"SE Kumar","year":"2022","unstructured":"Kumar SE, Goel A, Zachariah U, Nair SC, David VG, Varughese S, Gandhi PB, Barpha A, Sharma A, Vijayalekshmi B, Balasubramanian KA. Low volume plasma exchange and low dose steroid improve survival in patients with alcohol-related acute on chronic liver failure and severe alcoholic hepatitis\u2013preliminary experience. J Clin Exp Hepatol. 2022;12(2):372\u20138.","journal-title":"J Clin Exp Hepatol"},{"key":"7505_CR14","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.jceh.2015.07.037","volume":"5","author":"S Sidhu","year":"2015","unstructured":"Sidhu S, Goyal O, Gupta A, Kishore H, Gupta A. Corticosteroids and bovine colostrum in treatment of alcoholic hepatitis \u2018in extremis\u2019: a pilot study. J Clin Exp Hepatology. 2015;5:S19\u201320.","journal-title":"J Clin Exp Hepatology"},{"issue":"12","key":"7505_CR15","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.3390\/nu14122512","volume":"14","author":"H Dziewiecka","year":"2022","unstructured":"Dziewiecka H, Buttar HS, Kasperska A, et al. A systematic review of the influence of bovine colostrum supplementation on leaky gut syndrome in athletes: diagnostic biomarkers and future directions. Nutrients. 2022;14(12):2512\u20133.","journal-title":"Nutrients"},{"key":"7505_CR16","doi-asserted-by":"publisher","first-page":"673708","DOI":"10.3389\/fimmu.2021.673708","volume":"12","author":"Y Kinashi","year":"2021","unstructured":"Kinashi Y, Hase K. Partners in leaky gut syndrome: intestinal dysbiosis and autoimmunity. Front Immunol. 2021;12:673708.","journal-title":"Front Immunol"},{"key":"7505_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/medicina56100495","volume":"56","author":"M Ha\u0142asa","year":"2020","unstructured":"Ha\u0142asa M, Maciejewska-Markiewicz D, Ba\u015bkiewicz-Ha\u0142asa M, Safranow K, Stachowska E. Post-delivery milking delay influence on the effect of oral supplementation with bovine colostrum as measured with intestinal permeability test. Medicina. 2020;56:495.","journal-title":"Medicina"},{"key":"7505_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s13594-015-0258-x","volume":"96","author":"BA McGrath","year":"2016","unstructured":"McGrath BA, Fox PF, McSweeney PLH, et al. Composition and properties of bovine colostrum: a review. Dairy Sci Technol. 2016;96:133\u201358.","journal-title":"Dairy Sci Technol"},{"issue":"40","key":"7505_CR19","doi-asserted-by":"publisher","first-page":"100907","DOI":"10.1016\/j.fbio.2021.100907","volume":"1","author":"R Mehra","year":"2021","unstructured":"Mehra R, Singh R, Nayan V, et al. Nutritional attributes of bovine colostrum components in human health and disease: a comprehensive review. Food Biosci. 2021;1(40):100907.","journal-title":"Food Biosci"},{"issue":"10","key":"7505_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1017\/S0007114520000380","volume":"123","author":"E Amabebe","year":"2020","unstructured":"Amabebe E, Robert FO, Agbalalah T, Orubu ES. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020;123(10):1127\u201337.","journal-title":"Br J Nutr"},{"issue":"2","key":"7505_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0021-9673(97)01030-3","volume":"795","author":"R Hahn","year":"1998","unstructured":"Hahn R, Schulz PM, Schaupp C, Jungbauer A. Bovine whey fractionation based on cation-exchange chromatography. J Chromatogr A. 1998;795(2):277\u201387.","journal-title":"J Chromatogr A"},{"issue":"5","key":"7505_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/aps.2013.200","volume":"35","author":"T Siqueiros-Cendon","year":"2014","unstructured":"Siqueiros-Cendon T, Arevalo-Gallegos S, Iglesias-Figueroa BF, Garc\u00eda-Montoya IA, Salazar-Mart\u00ednez J, Rasc\u00f3n-Cruz Q. Immunomodulatory effects of lactoferrin. Acta Pharmacol Sin. 2014;35(5):557\u201366.","journal-title":"Acta Pharmacol Sin"},{"key":"7505_CR23","first-page":"CD007137","volume":"6","author":"M Pammi","year":"2017","unstructured":"Pammi M, Suresh G. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2017;6:CD007137.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"7505_CR24","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.3168\/jds.S0022-0302(06)72386-4","volume":"89","author":"S Godden","year":"2006","unstructured":"Godden S, McMartin S, Feirtag J, Stabel J, Bey R, Goyal S, Metzger L, Fetrow J, Wells S, Chester-Jones H. Heat-treatment of bovine colostrum. II: effects of heating duration on pathogen viability and immunoglobulin G. J Dairy Sci. 2006;89(9):3476\u201383.","journal-title":"J Dairy Sci"},{"key":"7505_CR25","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3168\/jds.2011-5220","volume":"95","author":"M Donahue","year":"2012","unstructured":"Donahue M, Godden SM, Bey R, et al. Heat treatment of colostrum on commercial dairy farms decreases colostrum microbial counts while maintaining colostrum immunoglobulin G concentrations. J Dairy Sci. 2012;95:2697\u2013702.","journal-title":"J Dairy Sci"},{"key":"7505_CR26","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.3168\/jds.2011-5275","volume":"95","author":"SM Godden","year":"2012","unstructured":"Godden SM, Smoelnski DJ, Donahue M, et al. Heat-treated colostrum and reduced morbidity in preweaned dairy calves: results of a randomized trial and examination of mechanisms of effectiveness. J Dairy Sci. 2012;95:4029\u201340.","journal-title":"J Dairy Sci"},{"key":"7505_CR27","doi-asserted-by":"publisher","first-page":"01100","DOI":"10.3389\/fphar.2020.01100","volume":"11","author":"S Bagwe-Parab","year":"2020","unstructured":"Bagwe-Parab S, Yadav P, Kaur G, Tuli HS, Buttar HS. Therapeutic applications of human and bovine colostrum in the treatment of gastrointestinal diseases and distinctive cancer types: the current evidence. Front Pharmacol. 2020;11:01100.","journal-title":"Front Pharmacol"},{"issue":"1","key":"7505_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.12944\/CRNFSJ.1.1.04","volume":"1","author":"ML Godhia","year":"2013","unstructured":"Godhia ML, Patel N. Colostrum - its composition, benefits as a nutraceutical - a review. Curr Res Nutr Food Sci. 2013;1(1):37\u201347.","journal-title":"Curr Res Nutr Food Sci"},{"issue":"6","key":"7505_CR29","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3390\/nu13061956","volume":"13","author":"K Chandwe","year":"2021","unstructured":"Chandwe K, Kelly P. Colostrum therapy for human gastrointestinal health and disease. Nutrients. 2021;13(6):1956.","journal-title":"Nutrients"},{"issue":"1","key":"7505_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/BF00210962","volume":"71","author":"A Stoehr","year":"1993","unstructured":"Stoehr A, Albrecht H, Meigel W. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea. Clinical Investig. 1993;71(1):42\u20135.","journal-title":"Clinical Investig"},{"issue":"12","key":"7505_CR31","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/00006454-199812000-00010","volume":"17","author":"Sarker","year":"1998","unstructured":"Sarker, Shafiqul A, Casswall A, et al. Successful treatment of rotavirus diarrhea inchildrenwithimmunoglobulinfromimmunizedbovinecolostrum. Pediatr Infect Dis J. 1998;17(12):1149\u201354.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"7505_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/0264041031000101935","volume":"21","author":"JD Buckley","year":"2003","unstructured":"Buckley JD, Brinkworth GD, Abbott MJ. Effect of bovine colostrum on anaerobic exercise performance and plasma insulin-like growth factor I. J Sports Sci. 2003;21(7):577\u201388.","journal-title":"J Sports Sci"},{"key":"7505_CR33","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/00005768-200207000-00020","volume":"34","author":"JS Coombes","year":"2002","unstructured":"Coombes JS, Conacher M, Austen SK, et al. Dose effects of oral bovine colostrums on physical work capacity in cyclists. Med Sci Sports Exerc. 2002;34:1184\u20138.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"7505_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00024382-200201000-00002","volume":"17","author":"E Bolke","year":"2002","unstructured":"Bolke E, Jehle PM, Hausmann F, Daubler A, Wiedeck H, Steinbach G, Storck M, Orth K. Preoperative oral application of immunoglobulin-enriched colostrums milk and mediator response during abdominal surgery. Shock. 2002;17(1):9\u201312.","journal-title":"Shock"},{"issue":"22","key":"7505_CR35","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.3748\/wjg.v26.i22.2916","volume":"26","author":"U Kamran","year":"2020","unstructured":"Kamran U, Towey J, Khanna A, Chauhan A, Rajoriya N, Holt A. Nutrition in alcohol-related liver disease: Physiopathology and management. World J Gastroenterol. 2020;26(22):2916\u201330.","journal-title":"World J Gastroenterol."},{"key":"7505_CR36","doi-asserted-by":"crossref","unstructured":"Tsien CD, McCullough AJ, Dasarathy S, et al. Late evening snack: exploring a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol. 2012;27:430e41.","DOI":"10.1111\/j.1440-1746.2011.06951.x"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07505-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07505-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07505-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T11:42:38Z","timestamp":1700307758000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07505-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7505"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07505-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2504765\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"11 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"515"}}